Sonoma Bio inks $75M deal with Regeneron to advance cell therapies against autoimmunity by Charlotte Schubert on March 28, 2023March 28, 2023 at 11:54 am The news: Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn’s disease and other autoimmune conditions. The agreement comes with a $75 million upfront payment and a… Read More